Whitehawk Therapeutics

(NASDAQ) WHWK

Current Price$4.16

Market Cap$205.72M

Since IPO (2021)-84%

5 Year-87%

1 Year+104%

1 Month-16%

Whitehawk Therapeutics Financials at a Glance

Market Cap

$205.72M

Revenue (TTM)

$0.00

Net Income (TTM)

-$115.81M

EPS (TTM)

-$1.67

P/E Ratio

-2.48

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Price

$4.16

Volume

161,368.087

Open

$4.06

Price

$4.16

Volume

161,368.087

Open

$4.06

Previous Close

$4.16

Daily Range

$4.06 - $4.34

52-Week Range

$1.57 - $5.50

Estimated Earnings Date

Aug 6, 2026

Dividend

$0.00

Beta (Volatility)

1.06 (Average)

Price

$4.16

Volume

161,368.087

Open

$4.06

Previous Close

$4.16

Daily Range

$4.06 - $4.34

52-Week Range

$1.57 - $5.50

Estimated Earnings Date

Aug 6, 2026

WHWK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Whitehawk Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David Lennon, PhD

Website

www.whitehawktx.com

Headquarters

Pacific Palisades, CA 90272, US

WHWK Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-69%

Return on Capital

-1%

Return on Assets

-91%

Earnings Yield

-40.32%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$205.72M

Shares Outstanding

49.45M

Volume

161.37K

Avg. Volume

300.03K

Financials (TTM)

Gross Profit

$6.39M

Operating Income

-$114.40M

EBITDA

-$20.52M

Operating Cash Flow

-$97.43M

Capital Expenditure

-$552.00K

Free Cash Flow

-$97.99M

Cash & ST Invst.

$145.70M

Total Debt

$0.00

Whitehawk Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$205.72M

N/A

Market Cap/Employee

$5.14M

N/A

Employees

N/A

Net Income

-$22.19M

-130.4%

EBITDA

-$22.19M

-130.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$123.04M

-46.7%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-91.02%

N/A

Return on Invested Capital

-1.06%

N/A

Free Cash Flow

-$17.23M

-13.1%

Operating Cash Flow

-$17.23M

-14.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MGNXMacroGenics, Inc.

MGNXMacroGenics, Inc.$3.96-1.25%

ZNTLZentalis Pharmaceuticals, Inc.

ZNTLZentalis Pharmaceuticals, Inc.$3.75+6.53%

CNTXContext Therapeutics Inc.

CNTXContext Therapeutics Inc.$1.39-2.11%

OVIDOvid Therapeutics Inc.

OVIDOvid Therapeutics Inc.$2.30+4.07%

ONCYOncolytics Biotech Inc.

ONCYOncolytics Biotech Inc.$0.80-2.07%

PLRXPliant Therapeutics, Inc.

PLRXPliant Therapeutics, Inc.$1.13-0.88%

CLNNClene Inc.

CLNNClene Inc.$5.84+5.61%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About WHWK

What is the current price of Whitehawk Therapeutics?

Whitehawk Therapeutics is trading at $4.16 per share.

What is the 52-week range for Whitehawk Therapeutics?

Over the past 52 weeks, Whitehawk Therapeutics has traded between $1.57 and $5.50.

How much debt does Whitehawk Therapeutics have?

As of the most recent reporting period, Whitehawk Therapeutics reported total debt of $0.00.

How much cash does Whitehawk Therapeutics have on hand?

Whitehawk Therapeutics reported $34.79M in cash and cash equivalents in its most recent financial results.

What is Whitehawk Therapeutics’s dividend yield?

Whitehawk Therapeutics does not currently have a dividend yield.

Whitehawk Therapeutics

Whitehawk Therapeutics Financials at a Glance

WHWK News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Whitehawk Therapeutics

WHWK Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Whitehawk Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About WHWK

What is the current price of Whitehawk Therapeutics?

What is the 52-week range for Whitehawk Therapeutics?

How much debt does Whitehawk Therapeutics have?

How much cash does Whitehawk Therapeutics have on hand?

What is Whitehawk Therapeutics’s dividend yield?

Premium Investing Services